Welcome to the November issue of News Across Latin America, the quarterly publication for the ISPOR Latin America Consortium.
The November issue includes two featured articles on trending issues that you need to know during the ongoing novel coronavirus (COVID-19) pandemic (both articles are in Spanish):
- Dispositivos médicos prioritarios en el contexto del COVID-19”. Situación y tendencias
- Ética En La Toma De Decisiones durante COVID-19
This issue also includes the latest HEOR news reported by our members in the Latin America region, including updates on the COVID-19 pandemic, ISPOR regional chapter activities, and news from ISPOR Latin America Consortium and ISPOR headquarters. We encourage you to participate and contribute in advancing HEOR in Latin America – join ISPOR Latin America Consortium or submit your news by sending an email to: email@example.com.
ISPOR News Across Latin America Team
Table of Contents:
| Featured articles
| Regional News
| ISPOR Member News
| ISPOR Headquarter News
| About ISPOR Global Networks
| Featured articles
- Dispositivos médicos prioritarios en el contexto del COVID-19”. Situación y tendencias
- Ética En La Toma De Decisiones durante COVID-19
Value in Health Regional Issues – In the upcoming issue of Value in Health Regional Issues focused on the Latin America region, the article by Makdisse, et al, “What Do Doctors Think About Value-Based Healthcare? A Survey of Practicing Physicians in a Private Healthcare Provider in Brazil,” concluded that involving physicians in the discussion of value-based healthcare initiatives is critical for a successful value-driven transformation of healthcare.
The Latin America VIHRi will be published in December 2020, but there are currently several articles in press for viewing:
- Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence, According to the Brazilian Public Health System Perspective Fernando Zanghelini, Haliton Alves de Oliveira, Thales Brendon Castano Silva, Daniel da Silva Pereira, Gustavo Laine Araújo de Oliveira
- Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data Karin Hepp Schwambach, Mareni Rocha Farias, Giácomo Balbinotto Neto, Carine Raquel Blatt
- Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis Isis Polianna Silva Ferreira de Carvalho, Henry Maia Peixoto, Gustavo Adolfo Sierra Romero, Maria Regina Fernandes de Oliveira.
- Satisfaction With Healthcare Services Among Patients With Diabetes, Hypertension, and/or Dyslipidemia in Mexico: A Cross-Sectional Study Francisco-Javier Prado-Galbarro, Copytzy Cruz-Cruz, Ana-Estela Gamiño-Arroyo, Carlos Sanchez-Piedra
- The Real-World Evidence Transparency Initiative Published an Article on Improving Transparency and Trust in Non-interventional Research for Hypothesis Testing – The steering committee of the Real-World Evidence Transparency Initiative published a paper titled “Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative” in the September 2020 issue of Value in Health. The paper highlightsthe views and recommendations for improving real-world evidence transparency, especially for hypothesis evaluating treatment effect studies done with secondary data sources. Click here to read the full article.
- ISPOR Health Preference Research Special Interest Group Publishes Report – A recent report titled “Health Preference Research in Europe – A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions: Report of the ISPOR Stated Preference Research Special Interest Group” was published in July’s Value in Health themed issue on health preference research. To access the article, please click here. For more information on this special interest group, please click here.
| Regional News:
WHO: COVID-19 stabilizing in Brazil: According to the World Health Organization (WHO) the coronavirus is stabilizing in Brazil. This was reported by Michael Ryan , World Health Organization’s emergencies director, who told during a virtual press conference that there is a “clear downward trend in many parts of Brazil” and although the number of cases has stabilized there is still a lot of work to do. Latin America represents nearly 9% of the world’s population but has registered 40% of the total COVID-19 related deaths in the last months. For more information on the COVID-19 situation in Brazil, please click here.
Central America and the Caribbean:
The ISPOR Central America and Caribbean chapter will be offering an opportunity to learn about health economics in a short course. The topics that this course will explore are: Introductions to Health Economics, Health Economics in Decision Making, Understanding the Health Economics Studies And Interpretation Of Them among others. Please email the chapter at: firstname.lastname@example.org to learn more.
ISPOR Colombia Chapter held their VI Congress virtually on 22-24 September, addressing the theme “Where we are and where we are going from regulatory and financial sustainability perspectives?” In the opening session, presenters grappled with the key questions that the COVID-19 pandemic is posing to the Latin America region, including how health systems can apply HEOR and new disruptive technologies to supporting decisión making for a sustainable future. In the following days, there were numerous sessions on topics such as changing regulatory landscapes in the región, new contracting models, value frameworks, clinical study designs and adaptive studies with real-world evidence, machine learning, data analytics and future directions for the global HEOR. There were also updates from various decisión-making bodies throughout the Latin American región.
ISPOR headquarters was delighted to participate in the inauguration of the congress, providing a salutation and introduction to ISPOR initiatives in the Latin America region, and provide recognition to ISPOR Colombia Chapters impressive accomplishments. ISPOR Mexico chapter also participated by sharing a presentation focused on data analysis and the use of the latest computer techniques in data analytics to make better decisions. Finally, the congress offered an opportunity to introduce the new leadership and board for ISPOR Colombia Chapter, who presented their vision for carrying the chapter forward into continued success. To learn more about this important event or get involved with ISPOR Colombia Chapter, please send an email to: email@example.com
Cesar Alberto Cruz Santiago, PhD, MD
Technical Secretary, General Health Council
Ministry of Health Mexico
Últimos avances de COVID-19 y noticias del capítulo ISPOR México–Octubre 2020.
Hasta el 30 de septiembre en México se han registrado 730,317 casos confirmados, 76,430 defunciones, el porcentaje de ocupación hospitalaria para COVID-19 es del 23%
- Desconfinamiento paulatino de la población a nivel nacional en función de la presencia de contagios y casos hospitalizados empleando un sistema de semaforización, integrándose a lo que las autoridades han denominado como la Nueva Normalidad.
- Reconversión hospitalaria para mantenimiento de unidades COVID-19 y unidades de apoyo, pero reinicio de actividades de los centros hospitalarios para la atención de enfermedades No COVID-19
- Acuerdos Internacionales con laboratorios como Astra Zeneca, para impulsar el desarrollo de vacuna en el menor tiempo posible.
México continúa participando en al menos 24 estudios fase II y III para el desarrollo de vacunas contra el COVID-19 y también en la implementación de probables medidas terapéuticas eficaces.
Para la reintegración laboral deberán cubrirse algunos requisitos entre los que destacan: Aplicación de pruebas de laboratorio con recursos propios, contratación de personal médico o capacitación a colaboradores en la materia y cierre total de actividades durante 14 días si se registra un solo caso de COVID-19, a las mencionadas medidas se debe sumar una inversión obligatoria en equipo de protección personal, como cubrebocas, caretas o lentes de seguridad, así como la modificación de espacios de trabajo o hasta la sustitución de mobiliario para asegurar la distancia mínima de 1.5 metros que establece la sana distancia. La iniciativa privada calcula estos costos en alrededor de 10% de las inversiones totales de cada empresa para todo 2020.
Se ha fortalecido el sistema de información y registro con la finalidad de que sea seguro y eficaz para poder contar en tiempo real con un mejor control y conocimiento de los diferentes casos y facilitar la implementación de medidas y toma de decisiones a fin de modificar de manera favorable la historia natural de la enfermedad.
ISPOR Mexico Chapter Activities
ISPOR Mexico Chapter recently organized two academic sessions, including a seminar on 16 July 2020 covering the topic “Multicriteria Analysis in Times of COVID-19” presented by Dr Rubén Rojas, Chief Scientific Officer, Fractal EDM, Chile, which had 150 virtual attendees. On 6 August the chapter presented a webinar entitled “International Reference Pricing Global and Latin American Aspects” by Dr András Incze, University Lecturer on Healthcare Management, Baden- Wuerttemberg State University, Germany, and CEO, Akceso Advisors AG, Switzerland. The webinar enjoyed the participation of 176 virtual attendees. ISPOR Mexico Chapter is planning their next seminar which will focused on COVID-19 and challenges of the pandemic. If you are interested in participating in the next seminar, contact the chapter by sending an email to: firstname.lastname@example.org
Evolución de COVID-19 en Venezuela – Octubre 2020
Giustino Adesso. PharmD, MSc HE.,
HE Instructor, School of Pharmacy
Universidad Central de Venezuela.
ISPOR Venezuela Chapter President
La situación del COVID-19 en Venezuela desde que se inició la cuarentena en el mes de marzo, según reportan los voceros oficiales, acumula para fines del mes de septiembre, 621 personas fallecidas y 74.363 contagiados (i) Cabe destacar que casi un 27 % de los fallecimientos (165) se corresponden con trabajadores del sector salud. Por otro lado, el Ministro de Salud señaló en la Reunión Anual del Consejo Directivo de la OPS del 29 de septiembre que la morbilidad registrada es de 2,3 casos por cada 1000 habitantes y la mortalidad de 1,9 defunciones por cada 100000 habitantes y que Venezuela inició la fase de meseta de la curva del Covid19(ii.) Sin embargo, diversos epidemiólogos y académicos en el país lo cuestionan porque, en ausencia de información oficial sobre la capacidad diagnostica disponible, ese comportamiento de la curva podría deberse al hecho que no se estarían haciendo suficientes pruebas y no porque se haya disminuido la velocidad de transmisión(iii) En todo caso, las autoridades oficiales siguen insistiendo en las medidas de cuarentena bajo el esquema de 7 x 7, es decir, alternando una semana de flexibilidad para realizar diversas actividades económicas y sociales, con otra semana de cuarentena radicalizada con menos libertades de acción.
PAHO Efforts to combat COVID-19 in Latin America
In the midst of the COVID-19 pandemic, the Pan American Health Organization (PAHO) has led extensive cooperation efforts among countries in Latin America to build capacities and support coordination of the COVID-19 responses, as outlined in the 2020 Annual Report of the PAHO Director “Saving Lives and Improving Health and Well-Being.” The report summarizes PAHO’s strategies and activities around the areas of supporting health systems and services, communicable diseases and noncommunicable diseases, mental health and more, and the report highlights special efforts to safeguard health for vulnerable populations both during and beyond the pandemic, emphasizing PAHO’s commitment to “leave no one behind.” “The health, social, and economic impacts of the pandemic will have far-reaching effects on progress for the achievement of national, sub regional, regional, and global health goals; on health financing and resource mobilization; and on our efforts and aspirations for health development with equity,” said Dr Carissa F. Etienne Etienne, PAHO Director in the report. To view the report, please visit here.
| ISPOR Member news:
HTA’s Evolving Role through the COVID Pandemic and Beyond – Virtual ISPOR 52nd HTA Roundtable – Latin America
The COVID-19 pandemic has laid bare vulnerabilities in health systems across the globe, and health technology assessment (HTA) bodies are facing significant pressure to adapt to the new realities. Given the need for greater clarity around HTA’s role in the pandemic and beyond, ISPOR hosted a timely virtual HTA roundtable discussion October 15, 2020. The ISPOR HTA Roundtable – Latin America is an invitation-only discussion table for government policymakers, healthcare payers and HTA experts from Latin America to discuss the topics pertinent to HTA and healthcare decision-making to make HTA more effective and harmonized for the region.
The roundtable agenda covered presentations on the topics “Rapid Reviews of COVID-19 Treatments and Lack of Cost and Economic Data: How to Handle?” by Dr Sebastian Garcia-Marti of the Instituto de Efectividad Clinica y Sanitaria (IECS), Argentina, and “Allocation of Medical Devices in the Hospital Setting – How to Prioritize?” by Dr Cesar Cruz, General Health Council, Mexico. The presentations were followed by robust discussions among the delegates, facilitated by Dr Manuel Espinoza of Pontificia Universidad Católica de Chile, Santiago, Chile. There was also an update by ISPOR HTA Council Chair Dr Brian O’Rourke on the ISPOR Global COVID-19 Survey results. The roundtable enjoyed representation from numerous health organizations, HTA and decision-making bodies in the region including but not limited to the Pan American Health Organization (PAHO), RedArets and IECS (Argentina), RedETSA, Bermuda Health Council, ANS (Brazil), CENETEC and IMSS (Mexico), CCSS (Costa Rica), ARSA (Honduras), MSP (Uruguay) and more.
The robust discussions that resulted from the roundtable have fueled sharp interest in the Latin America HTA community to continue to engage and join forces to strengthen HTA best practices and frameworks for the region. Stayed tuned for more news on this in the coming months – a comprehensive summary of the discussion points is also being developed and will be shared soon with ISPOR community. To learn more about these and other initiatives, please visit www.ispor.org or contact email@example.com.
Global Experiences with the Use of HTA for Health Benefit Packages Development
Over 270 people participated in a webinar organized by the ISPOR Global Networks on 26 August 2020 to learn from our regional experts about the role of Health Technology Assessment (HTA) in Universal Health Coverage (UHC), and understanding how HTA could support designing benefits package for UHC while tackling the encountered challenges. This brief summarizes a couple of reflections from these experts.
Dr Ramiro Gilardino, Sr. Researcher in Global Health Policy opened the webinar by providing a brief overview of the role HTA shaping health benefits packages (HBP) and the key challenges for their implementation in the context of UHC. Dr Dominik Dziurda, Head of Health Services Division, Agency for Health Technology Assessment and Tariff System (AOTMiT) presented Poland’s experience in expanding the scope of HTA from single technology appraisal towards strategic system-transformative projects. He explained critical milestones accomplished over the past 15 years in the development of HTA and recent years the use of HTA in value-based healthcare services. Dr Raoh-Fang (Jasmine) Pwu, Director of National Hepatitis C Program Office of Taiwan Ministry of Health and Welfare, shared her experience by introducing historical development of the HTAsiaLink and lessons she learned from that as a founding member of the Network. Dr Veronica Gallegos, Deputy Director of National Center for Health Technology Excellence (CENETEC), Mexico, presented Latin American perspectives on the use of HTA in UHC. She briefly overviewed the role of HTA in health system and achievements in HTA in LAC following by highlighting key milestones on the path to UHC over the past few decades and the challenges facing HTA.
What is the Role of Benefits Package Development to Shape UHC?
UHC aims to provide broad access by citizens to qualified health services and financial protection from catastrophic health expenditures. Although many countries implemented healthcare systems changes improving the services coverage by shaping primary healthcare, they struggle to find a mechanism to expand these services and to increase measures to guarantee financial protection and reduce catastrophic spending. Prioritized health services baskets, also called health benefits packages (HBP), are cost-effective by increasing the service delivery (e.g., pharmaceutical products, medical devices, diagnostics tests, and diagnostic/therapeutic procedures) while reducing the cost of these pooled services, improving the UHC index. The newly defined HTA perfectly fits as a decision support tool for the HBP development, for example, exploring to review and summarize the comparative evidence of healthcare interventions.
Use of HTA for Health Benefit Packages Development – Latin American Perspectives
Universal Health Coverage includes elements like equity, type of service coverage, quality of health services, and affordability. The health systemsin Latin American countriesare characterized by fragmentation and segmentation, which generates inequalities, difficulties in access, less quality in health care services, irrational and inefficient use of resources. In the last decades Latin American countries have been in health system reforms and trying to increase the effective coverage and financial risk protection through health benefit packages, reflected as a reduction in out-of-pocket spending. Health technologies represent an indicator of efficiency and equity of health systems, their acquisition could generate a high impact on the budget and a significant out-of-pocket expense of individuals and their families without coverage policies. Therefore, HTA provides reliable and useful information for decision-making, support the prioritization of health interventions and technologies for public funding, reimbursement decisions, and public policies on coverage. The region has achieved a remarkable HTA development over the past decade, many countries are moving towards the institutionalization of HTA and increasing use in priority setting and decision-making process. Currently at least 19 countries have a process of HTA through the Ministry of Health, HTA agencies, non-government organizations, or academies bodies. Organizations and networks as RedETSA through PAHO, ISPOR, HTAi and INAHTA have a fundamental role in promoting HTA in the region
Extending the Scope of HTA in Poland
Poland has a single-payer system that provides universal healthcare insurance, with a central governmental HTA Agency (www.aotm.gov.pl). First comprehensive HTA guidelines were created in 2007 (last updated in 2016) and the formal health benefit package was introduced in 2009. Since 2015 Poland has been extending the scope of HTA, from a single technology appraisal (mainly of medicinal products) towards strategic, transformative projects and independent, scientifically based calculation of health services’ tariffs. HTA plays an important role in legal and organizational layers determining access to health care. The so called “rapid reviews” aid process management and serve as a basis for formulation of national comprehensive recommendations in COVID-191. Here is what we have learned from Poland’s experience: 1) For HTA to become a significant tool in shaping healthcare system, HTA bodies must achieve a functional capability to carry-out strategic, large-scale analytical processes, and evidence-based medicine (EBM)-way-of-thinking needs to be internalized and actively advocated by critical stakeholders; 2) Reimbursement processes for medicinal products across EU are generally based on or supported by HTA and its effectiveness can be used as a springboard for creation of a more value-driven healthcare system; 3) Growing responsibility, such as volume, diversity and complexity of EBM/HTA projects, is the main pivotal opportunity for further development of HTA, and 4) Access to unified healthcare data in a single-payer system facilitates both analysis of the current situation and arrangement of sound changes in the healthcare system. (1. https://www.aotm.gov.pl/zalecenia-kliniczne/covid-19/).
Use of HTA for Health Benefit Packages Development – APAC Experience
There is a growing commitment to pursuing UHC in Asia Pacific, but the pace of development of UHC across the region is quite varied. According to the latest WHO’s UHC service coverage index, the region has scores varying from 0.5 to over 0.8, indicating that countries in the region are in different stages of UHC. Many countries echoed WHO’s call for actions on building up health technology assessment functions to assist the policymaking for UHC. However, it is never an easy task. Under these circumstances, HTAsiaLink, a network of HTA agencies in Asia established in 2011 with the aim of strengthening individual and institutional HTA capacity, transfer and share HTA-related lessons among member countries that are in various UHC stages. In one of the regional collaborative projects, some key factors for successfully establishing HTA agencies have been identified for each country to consider. These factors include independence, financial sustainability, management of conflicts of interest, full-time multidisciplinary staff, extensive networks, good systematic processes, and high-quality research with a quality assurance mechanism. Because the member organizations faced capacity training issues and could not afford to get international standard training for their young staff, in 2012 the HTAsiaLink started to hold its annual conference that focuses on the development of HTA capacity. The conference provides great opportunities to junior staff of members organizations for learning and networking. All these efforts have been contributing the progress of UHC in each member country.
ISPOR Outstanding Regional Chapter Award 2020 Winners
Congratulations to ISPOR Mexico Chapter, ISPOR Mongolia Chapter, and ISPOR Austria Chapter for being recognized with the ISPOR 2020 Outstanding Regional Chapter Award. The ISPOR Outstanding Regional Chapter Award recognizes outstanding contributions and leadership of ISPOR Regional Chapters in advancing the ISPOR mission in ISPOR global regions. The award is offered in small, medium, and large Chapter categories. Stay tuned for the special featured interviews with this year’s awardees in ISPOR Value & Outcomes Spotlight magazine this November/December 2020. Lessons learned during COVID-19 and how they see the future of health care and the role of HEOR on the post-pandemic world were some of the questions that we queried them regarding. To learn more about this award click here.
ISPOR Chapter Leadership Training 2020
Chapter Leader Training 2020 – These interactive trainings are designed for ISPOR Regional Chapter and ISPOR Consortium leaders to support capacity building and leadership development. The trainings provide information on recent trends related to HEOR methodology or health policy, and they also equip ISPOR leaders with techniques to be successful in their ISPOR leadership roles.
- The 4th Industrial Revolution, Digital Transformation and Patient Centricity: A Leadership View – When: 15 December 2020 at 10:00 AM Eastern Time (US and Canada)– Click here to register!
In this presentation we will explore what the 4th Industrial Revolution is, how it impacts on the progressive movement towards digital transformation in our workplace. We will show that there is an inevitable convergence between the health ecosystem and the digital world. Importantly we will link these disruptive changes to how it might advance patient centric approaches in our work and what leaders should be prepared for, how to equip themselves and practical examples to embrace this change. Given our leadership roles in our Chapters, examples and experience of how to lead this change successfully will be explored from a Chapter and Global experience.
Did you miss the additional trainings offered this year? You still have an opportunity to watch them on-demand:
- The Leader’s Vision: Value-Based Medicine and Leadership Training – 28 April 2020. 9:00 AM EST. Presented in Spanish. – Click here to see the recorded webinar
- Role of Digital Therapeutics in Reshaping the Future of Healthcare – 15 July 2020. 8:00 am EST. Click here to see the recorded webinar. and read the summary here.
Recent Global Networks Webinars:
Focused on Latin America:
- The Usage of Real-World Evidence (RWE): Monitoring and Managing Health Technologies in Latin America – Where We Are and Where We Are Heading. Hosted by the Latin America Industry Committee. This webinar described the Latin American trends in the use of RWE, and outlined the current stage, challenges, and opportunities for the use of it in the regional decision-making process, as well as described the technical challenges for RWE from both global and regional perspectives. Watch the webinar here.
- The Industry Committee of the ISPOR Latin America Consortium and the “Real-World Evidence Working Group (RWE)”, invites you to participate in a survey that aims to understand how RWE is used throughout Latin America in the healthcare decision-making process: https://www.surveymonkey.com/r/RWELatam We appreciate your participation!
Focused on Asia Pacific:
- Patient Reported Outcomes in Asia Pacific: Opportunity and Challenges
Hosted by the Asia Consortium, this webinar features speakers from Japan, Taiwan, and Hong Kong which discuss the importance, strengths, and limitations of patient-reported outcomes. Watch the webinar here.
Educational Webinar Offerings from ISPOR Special Interest Groups:
- Why and How to Use Qualitative Research Methods in Conjunction with Discrete Choice Experiments in Health Care
- Open Source Models in HEOR: Benefits, Challenges, and ISPOR Members’ Perceptions
- Recordings coming soon to the ISPOR Webinars webpage:
- “Biosimilars: Unleashing the Potential for Improved Patient Access and Cost Savings in the United States”
- “One Health Perspectives on HEOR”
- “Patient-Reported Outcomes: Development, Use and Patient Engagement” – a 3-part webinar series
| ISPOR Headquarter news:
The newly designed Virtual ISPOR Europe 2020 includes a series of on demand sessions leading up to the conference, available now, in addition to 4 days of live virtual programming, and a subscription to access all content through 31 December 2020. (All sessions presented in Central European Time – UTC +1).
- ISPOR Global Networks presentations during ISPOR Virtual Europe 2020, will bring to you the opportunity to stay aware of relevant topics in Latin America, Asia Pacific and EMEA regions. For this conference you’ll have access to both on demand and live group discussion sessions. We hope you can participate in the activities that we have prepared for you:
- Latin America:
On Demand – “Practical Applications: How HEOR is Advancing Access, Value and Affordability in Healthcare in Latin America.” Presented by the ISPOR Latin America Consortium
On Demand – “Real-World Evidence for Medtech Value Assessment in Asia Pacific – Where are we Heading?” Presented by the ISPOR Asia Consortium Industry Committee
On Demand – “The Transferability of HTA: European Perspectives with Focus on Central and Eastern European Countries.” Presented by the ISPOR CEE Consortium
Group Discussion – “Effect of Public and Private Partnerships in Healthcare Financing to Improve Health Outcomes.” Presented by the ISPOR Arabic Network
For more information visit the Conference program here.
- ISPOR Women in HEOR Initiative
The COVID-19 pandemic has upended the careers and personal lives of millions across the globe. In the upcoming weeks, leaders of the ISPOR Women in HEOR Initiative will be launching polls on how HEOR professionals can transition to the next phase of the “new normal” with an eye towards long-term career success. These polls will be available on ISPOR Women in HEOR LinkedIn Discussion Group. We encourage all to interact with the polls and share your strategies for balancing work and personal wellness in this evolving COVID-19 working world. The results of these polls will guide a live panel discussion titled “Adapting to the ‘New Normal’” at the upcoming Virtual ISPOR Europe 2020 conference (16-19 November 2020). To register for the Conference, please click here: www.ispor.org/Europe2020. For more information on the Initiative, please click here: www.ispor.org/WomenInHEOR
- Virtual ISPOR-FDA Summit 2020
On 29 September 2020, ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) presented their jointly developed Virtual ISPOR-FDA Summit 2020, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond.” This Summit provided a forum to engage all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators, who discussed and explored the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem. Full Summit content, including the recording of all sessions, speaker slides, and transcript, will be publicly available online on the ISPOR and FDA CDRH webpages by the end of October 2020. Also consider viewing an ISPOR Educational Webinar on this topic: Patient-Preference Information – What It Is and What It Is Not.
- Join us in the new ISPOR COVID-19 Member Community, an exclusive benefit available only for ISPOR members. The ISPOR COVID-19 Community is an exciting collaborative platform where you can share ideas, discuss challenges, and post questions related to COVID-19.
- Update from the ISPOR Task Forces – The ISPOR Measurement Comparability Between Modes of Administration of PROMs Good Practices Task Force presented “When Does Mode of Data Collection Matter? Updated and Expanded Recommendations for Collecting PRO Measures Electronically in Clinical Trials.” The slides and presentation are available here.
- ISPOR Patient Centered Special Interest Group Reports and Webinar
The ISPOR Patient-Centered Special Interest Group recently launched a consensus definition of “Patient Engagement in Research”, representing a significant achievement for the group. Below are various channels through which this work has been disseminated. All content is available open access, without a paywall. If you have examples or reflections on how you have implemented the new “Patient Engagement in Research” definition, we want to hear from you! Please share your successes, challenges, and use cases with us by emailing to firstname.lastname@example.org.
- “Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group” Value in Health Vol 22, Issue 6 | ISPOR Press Release.
- “From the Patients: Defining Patient Engagement in Research “, Value and Outcomes Spotlight July/August 2020 .
- “Patient Engagement in Research: An ISPOR Definition” Educational Webinar, on-demand July 17, 2020
There is more!
To learn about the latest HEOR news in (Asia Pacific / EMEA) and read about activities and initiatives of ISPOR global groups in the (Asia Pacific / EMEA) regions, please access the November 2020 issues of News Across Asia-Pacific , November 2020 issue of News Across EMEA.
ISPOR News Across provides a valuable platform for information sharing for readers and advertisers alike. The ISPOR News Across editions are highly read by our ISPOR members and key opinion leaders globally, and there are opportunities to participate by advertising digitally in these publications in 2 different formats – 1) a horizontal banner (600×180 pixels) at $800, or 2) a small rectangle (300×250 pixels) at $500. Please contact email@example.com for more information.
ABOUT ISPOR LATIN AMERICA CONSORTIUM
The ISPOR Latin America Consortium is comprised of professionals interested in promoting health economics and outcomes research (HEOR) excellence to improve healthcare decision making in Latin America and globally. The Latin America consortium provides a platform for information-sharing and institutional collaboration on HEOR and health policy, facilitating professional networking opportunities through scientific activities and global ISPOR initiatives. Information, or to join, please contact firstname.lastname@example.org.